Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axcella Health Inc (AXLA)

Axcella Health Inc (AXLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axcella Health Inc 840 MEMORIAL DRIVE P.O. BOX 1270 LITTLETON MA 01460 USA

www.axcellahealth.com P: 857-320-2200

Description:

Axcella Health Inc. is a biotechnology company. It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's principal candidate consists of AXA1665, AXA1125, AXA1957, AXA2678 and AXA4010 which are in clinical stage. Axcella Health Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,182
Enterprise Value, $K -15,968
Shares Outstanding, K 2,948
Annual Sales, $ 0 K
Annual Net Income, $ -81,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,410 K
EBIT, $ -41,570 K
EBITDA, $ -41,160 K
60-Month Beta 0.57
% of Insider Shareholders 2.20%
% of Institutional Shareholders 65.07%
Float, K 2,883
% Float 97.80%
Short Volume Ratio 0.26

Growth:

1-Year Return -95.14%
3-Year Return -99.69%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.25 on 08/03/23
Next Earnings Date 01/02/24
Earnings Per Share ttm -18.75
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 87.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 09/19/23

AXLA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -259.91%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.77
Interest Coverage -25.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar